ArticleslgStudy

science

Lorvotuzumab mertansine

Lorvotuzumab mertansine is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Lorvotuzumab mertansine rather than just read about it. In short: Lorvotuzumab mertansine (IMGN901) is an antibody-drug conjugate. It comprises the CD56-binding antibody, lorvotuzumab (huN901), with a maytansinoid cell-killing agent, DM1, attached using a disulfide linker, SPP.

Lorvotuzumab mertansine — main illustration
Lorvotuzumab mertansine — illustration

Key takeaways

  • Lorvotuzumab mertansine belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Lorvotuzumab mertansine to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Lorvotuzumab mertansine from memory before moving on to harder problems.

Reference excerpt

Lorvotuzumab mertansine (IMGN901) is an antibody-drug conjugate. It comprises the CD56-binding antibody, lorvotuzumab (huN901), with a maytansinoid cell-killing agent, DM1, attached using a disulfide linker, SPP. (When DM1 is attached to an antibody with the SPP linker, it is mertansine; when it is attached with the thioether linker, SMCC, it is emtansine.) Lorvotuzumab mertansine is an experimental agent created for the treatment of CD56 positive cancers (e.g. small-cell lung cancer, ovarian cancer). It has been granted Orphan drug status for Merkel cell carcinoma. It has reported encouraging Phase II results for small-cell lung cancer.

References

Illustrations

Lorvotuzumab mertansine illustration

Worked examples

Example 1 — a first encounter with Lorvotuzumab mertansine

Start with the simplest possible case. Write down what Lorvotuzumab mertansine claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Lorvotuzumab mertansine before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Lorvotuzumab mertansine ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Lorvotuzumab mertansine

In research
Lorvotuzumab mertansine appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Lorvotuzumab mertansine in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Lorvotuzumab mertansine is common in secondary-school and first-year university syllabi. It links to neighbouring topics Antibody–drug conjugate, Antineoplastic and immunomodulating drug stubs, Drugs not assigned an ATC code, so understanding it makes those chapters shorter.
In everyday life
Look for Lorvotuzumab mertansine outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Lorvotuzumab mertansine” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Lorvotuzumab mertansine in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Lorvotuzumab mertansine means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Lorvotuzumab mertansine out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Lorvotuzumab mertansine in simple terms?

Lorvotuzumab mertansine (IMGN901) is an antibody-drug conjugate. It comprises the CD56-binding antibody, lorvotuzumab (huN901), with a maytansinoid cell-killing agent, DM1, attached using a disulfide linker, SPP.

Why does Lorvotuzumab mertansine matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Lorvotuzumab mertansine?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Lorvotuzumab mertansine.

Tags

  • Antibody–drug conjugate
  • Antineoplastic and immunomodulating drug stubs
  • Drugs not assigned an ATC code
  • Experimental cancer drugs
  • Monoclonal antibodies for tumors
  • Monoclonal antibody stubs

Keep exploring